Error loading player: No playable sources found
T106
Panel Discussion
Date
April 28, 2020
This product is not available for individual purchase, but it is available as part of the following products:
Speakers
Sanofi
Ultragenyx Pharmaceutical Inc
Kite, a Gilead Company
Health Canada
Tracks
Related Products
Development of a Platform Potency Assay for AAV Gene Therapy Products
Ultragenyx Gene Therapy is focused on advancing AAV-based gene therapies for rare, but serious, genetic diseases. Potency assessment for such advanced therapeutic product is of critical importance, but can also be very challenging…
Development and Qualification of a Reporter Gene Potency Assay to Support
The development of a relative potency assay to support biologic drug products requires significant budget, resources, and time to achieve the desired quality for release testing…
Flow into the Future: Development of a Lean, Robust and Scalable Method for Commercial Release of a Cellular Therapy Product
Engineered cellular therapy products are among the more complex of immunotherapeutic modalities because they are living drugs…
Bioassays for Cell and Gene Therapy
With increasing numbers of cell and gene therapy products in development and entering commercialization, more and more sponsors are facing a unique set of challenges of developing bioassays for cell and gene therapy products…
